Matteo Guardiani

Gordian Edenhofer, Philipp Frank, Jakob Roth et al.

Imaging is the process of transforming noisy, incomplete data into a space that humans can interpret. NIFTy is a Bayesian framework for imaging and has already successfully been applied to many fields in astrophysics. Previous design decisions held the performance and the development of methods in NIFTy back. We present a rewrite of NIFTy, coined NIFTy.re, which reworks the modeling principle, extends the inference strategies, and outsources much of the heavy lifting to JAX. The rewrite dramatically accelerates models written in NIFTy, lays the foundation for new types of inference machineries, improves maintainability, and enables interoperability between NIFTy and the JAX machine learning ecosystem.

Matteo Guardiani, Philipp Frank, Andrija Kostić et al.

The viral load of patients infected with SARS-CoV-2 varies on logarithmic scales and possibly with age. Controversial claims have been made in the literature regarding whether the viral load distribution actually depends on the age of the patients. Such a dependence would have implications for the COVID-19 spreading mechanism, the age-dependent immune system reaction, and thus for policymaking. We hereby develop a method to analyze viral-load distribution data as a function of the patients' age within a flexible, non-parametric, hierarchical, Bayesian, and causal model. The causal nature of the developed reconstruction additionally allows to test for bias in the data. This could be due to, e.g., bias in patient-testing and data collection or systematic errors in the measurement of the viral load. We perform these tests by calculating the Bayesian evidence for each implied possible causal direction. The possibility of testing for bias in data collection and identifying causal directions can be very useful in other contexts as well. For this reason we make our model freely available. When applied to publicly available age and SARS-CoV-2 viral load data, we find a statistically significant increase in the viral load with age, but only for one of the two analyzed datasets. If we consider this dataset, and based on the current understanding of viral load's impact on patients' infectivity, we expect a non-negligible difference in the infectivity of different age groups. This difference is nonetheless too small to justify considering any age group as noninfectious.